Every 2 years, CISCRP conducts a global study on public and patient views of clinical research. These studies have been conducted since 2013 and help to establish a routine global assessment of trends in perceptions and clinical research experiences. Industry stakeholders can use these reports to identify opportunities to better inform and engage all stakeholders and partners in the clinical research enterprise. CISCRP receives input and support from biopharmaceutical companies, contract research organizations, industry service providers, patient advocates/advocacy groups, and investigative sites to execute the study.
AbbVie Corporation | AstraZeneca | Biogen | Bristol-Myers Squibb | Covance | EMD Serono | Greenphire | Janssen | Merck | Otsuka | Pfizer | YPrime | Clariness | AES | CureClick | Benchmark Research | IQVIA
Contact us to get started: info@ciscrp.org
Our reports are free-of-charge to the public and patients, but we request that research professionals and sponsors consider donating to our nonprofit organization in support of our ongoing efforts to research and understand study volunteer perceptions, experiences and behaviors.
Â
Dominantly Inherited Alzheimer’s Disease Brochure
Expanded Registry Flyer (English)
Enfermedad de Alzheimer de herencia dominante
Expanded Registry Flyer (Spanish)
Forgetting the Little Things
Concerned About Memory Loss?
 Â
Â
Â
Click on the resources listed below to view the full versions of LCI’s materials.Â
Missy Hansen MSN, APRN, CPNP, CPHON, joined ICON in 2019 as a pediatric strategy liaison. She has 25+ years of experience as a pediatric nurse practitioner, including 17+ years in pediatric hematology/oncology at Children’s Minnesota, the largest hematology/oncology service line in the region, providing care for infants through young adults diagnosed with hematologic and/or oncology conditions. Ms. Hansen gained expertise working in inpatient, outpatient, and urgent care type settings. Ms. Hansen has in-depth experience working with the Children’s Oncology Group—the largest consortium with the most open pediatric studies around the world. She also has experience working with other consortia that conduct trials for pediatric to young adult patients.
Subscribe to our newsletter:
Subscribe to our newsletter:
Subscribe to our newsletter:
Subscribe to our newsletter:
Subscribe to our newsletter:
Subscribe to our newsletter: